Rasagiline | High-Quality Pharmaceutical Reference Standard
Rasagiline is a selective monoamine oxidase-B (MAO-B) inhibitor used in the treatment of Parkinson’s disease. It works by inhibiting the breakdown of dopamine in the brain, improving motor function and reducing disease progression. Rasagiline API is produced under GMP standards and is suitable for oral tablet formulations.
Rasagiline API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 10
